| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |